3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Brain Neoplasms
31
Carcinoma, Non-Small-Cell Lung
27
Prostatic Neoplasms
26
Lung Neoplasms
20
Neoplasm Metastasis
19
Melanoma
12
Breast Neoplasms
12
Pancreatic Neoplasms
8
Carcinoma, Renal Cell
8
Carcinoma, Hepatocellular
7
Small Cell Lung Carcinoma
5
Colorectal Neoplasms
5
Neoplasms
4
Urinary Bladder Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
NSCLC
3
Meningioma
3
Hematologic Neoplasms
3
Gastrointestinal Neoplasms
3
Uveal Melanoma
2
Unresectable Locally Recurrent Rectal Cancer
2
Thyroid Neoplasms
2
Sarcoma
2
Liver Neoplasms
2
Head and Neck Neoplasms
2
Carcinoma, Transitional Cell
2
Carcinoma, Merkel Cell
2
Adenocarcinoma
2
Uterine Cervical Neoplasms
1
Urogenital Neoplasms
1
Interventions
X-Rays
6
Phantoms, Imaging
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
Nuclear Medicine Department, Hospital
5
Biopsy
4
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
LY3023414
2
talazoparib
1
olaparib
1
irinotecan sucrosofate
1
amino-acid, glucose, and electrolyte solution
1
Vemurafenib
1
Temozolomide
1
Pharmacogenomic Variants
1
Liquid Biopsy
1
177Lu-octreotide, DOTA(0)-Tyr(3)-
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive, Peripheral
×
Radiosurgery
×
90 days
×
Clear all
No trials found.